Structures by: Nangia A.


Structures by: Nangia A.

Results: 620


#NameUnit Cell
15052051:1 complex of barbituric acid and quinoxaline-N,N-oxide
Molecular Pharmaceutics (2007) 4, 3 417
a=10.3850(9)
b=7.2222(6)
c=16.3763(14)
α= 90.00
β= 93.6860(10)
γ= 90.00
V = 1225.72(18)
15052061:2 Cocrystal of Barbituric acid and 4-methylpyridine N-oxide
Molecular Pharmaceutics (2007) 4, 3 417
a=8.4083(7)
b=9.8893(9)
c=10.6761(9)
α= 73.2010(10)
β= 79.022(2)
γ= 74.182(2)
V = 811.64(12)
15052072:1 Cocrystal of Barbituric acid and 4,4pyrazine-N,N-dioxide
Molecular Pharmaceutics (2007) 4, 3 417
a=5.258(3)
b=6.478(3)
c=22.118(11)
α= 90.00
β= 95.795(8)
γ= 90.00
V = 749.5(7)
15052081:1 complex of saccharin and bipyridine-N,N-oxide
Molecular Pharmaceutics (2007) 4, 3 417
a=6.5207(4)
b=14.0377(9)
c=13.1232(9)
α= 90.00
β= 104.2800(10)
γ= 90.00
V = 1164.12(13)
15052092:1 cocrystal of 4-methylpyridine-N-oxide and barbital
Molecular Pharmaceutics (2007) 4, 3 417
a=7.2276(5)
b=19.5811(12)
c=9.9928(6)
α= 90.00
β= 98.1360(10)
γ= 90.00
V = 1399.99(15)
15052102:4 Cocrystal of Barbital acid and 4-methylpyridine N-oxide
Molecular Pharmaceutics (2007) 4, 3 417
a=8.2106(5)
b=23.9166(15)
c=20.6318(13)
α= 90.00
β= 96.6700(10)
γ= 90.00
V = 4024.0(4)
15052111:1 cocrystal of 4-hydroxybenzamide and bipyridine-N,N-dioxide
Molecular Pharmaceutics (2007) 4, 3 417
a=5.692(4)
b=9.482(6)
c=10.751(7)
α= 69.893(10)
β= 84.232(10)
γ= 84.969(10)
V = 541.2(6)
1505212Hydrate of 1:1 cocrystal of 4-hydroxy benzamide and pyrazine-4,4-dioxide
Molecular Pharmaceutics (2007) 4, 3 417
a=6.409(4)
b=7.372(4)
c=11.064(6)
α= 96.127(14)
β= 97.22(3)
γ= 105.350(9)
V = 494.7(5)
15052131:0.5 cocrystal of Carbamazepine and Quinoxaline-N,N-dioxide
Molecular Pharmaceutics (2007) 4, 3 417
a=7.284(2)
b=10.688(4)
c=14.132(5)
α= 100.250(5)
β= 102.463(5)
γ= 109.079(5)
V = 977.8(6)
15052141:0.5 cocrystal of Carbamazepine and pyrazine-N,N-dioxide
Molecular Pharmaceutics (2007) 4, 3 417
a=10.237(4)
b=27.247(12)
c=5.135(2)
α= 90.00
β= 102.708(7)
γ= 90.00
V = 1397.2(10)
15068332,3,5,6-pyrazinetetracarboxylic acid dihydrate
The Journal of Physical Chemistry A (2004) 108, 43 9406
a=5.4385(10)
b=6.3885(10)
c=8.6809(10)
α= 98.381(5)
β= 107.406(5)
γ= 105.573(5)
V = 268.72(7)
15068342,3,5,6-pyrazinetetracarboxylic acid dihydrate
The Journal of Physical Chemistry A (2004) 108, 43 9406
a=5.4606(10)
b=6.4133(10)
c=8.7164(10)
α= 98.962(5)
β= 107.408(5)
γ= 105.348(5)
V = 271.57(7)
15068352,3,5,6-pyrazinetetracarboxylic acid dihydrate
The Journal of Physical Chemistry A (2004) 108, 43 9406
a=5.4361(10)
b=6.3699(10)
c=8.6672(10)
α= 97.911(5)
β= 107.546(5)
γ= 105.718(5)
V = 267.48(7)
15068362,3,5,6-pyrazinetetracarboxylic acid dihydrate
The Journal of Physical Chemistry A (2004) 108, 43 9406
a=5.4950(10)
b=6.4410(10)
c=8.7670(10)
α= 99.393(6)
β= 107.565(7)
γ= 105.174(7)
V = 275.44(8)
15068372,3-Pyrazine dicarboxylic acid dihydrate
The Journal of Physical Chemistry A (2004) 108, 43 9406
a=5.3470(2)
b=13.0286(4)
c=11.7443(4)
α= 90.00
β= 99.0360(10)
γ= 90.00
V = 808.00(5)
1542812C6H8N2O2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=7.2731(4)
b=15.9052(10)
c=12.7766(6)
α= 90.00
β= 99.291(5)
γ= 90.00
V = 1458.61(14)
1542813C6H7NO2S,C7H13NO
IUCrJ (2015) 2, 4 389-401
a=7.3020(9)
b=17.189(2)
c=12.2835(16)
α= 90.00
β= 106.760(2)
γ= 90.00
V = 1476.3(3)
1542814C6H6ClNO2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=7.1564(13)
b=13.369(2)
c=15.276(3)
α= 90.00
β= 90.00
γ= 90.00
V = 1461.5(4)
1542815C6H8N2O2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=7.0957(6)
b=13.1280(13)
c=15.3425(18)
α= 90.00
β= 90.00
γ= 90.00
V = 1429.2(3)
1542816C6H6BrNO2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=7.156(3)
b=13.538(5)
c=15.406(6)
α= 90.00
β= 90.00
γ= 90.00
V = 1492.5(10)
1542817C7H9NO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=5.3367(6)
b=15.9206(17)
c=16.070(3)
α= 90.00
β= 98.308(12)
γ= 90.00
V = 1351.0(3)
1542818C6H6ClNO2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=9.8782(6)
b=14.1720(6)
c=10.8753(6)
α= 90.00
β= 112.850(7)
γ= 90.00
V = 1403.00(15)
1542819C6H7NO2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=7.0700(9)
b=12.7624(13)
c=14.977(2)
α= 90.00
β= 90.00
γ= 90.00
V = 1351.4(3)
1542820C6H6ClNO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=25.701(4)
b=6.8096(4)
c=19.177(3)
α= 90.00
β= 127.40(2)
γ= 90.00
V = 2666.2(9)
1542821C6H6BrNO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=25.914(3)
b=6.8687(9)
c=19.202(2)
α= 90.00
β= 126.873(2)
γ= 90.00
V = 2734.2(6)
1542822C7H9NO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=5.210(3)
b=8.449(4)
c=16.104(8)
α= 82.894(8)
β= 82.798(8)
γ= 81.772(8)
V = 692.0(6)
1542823C6H6ClNO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=10.521(2)
b=13.7661(12)
c=10.3407(16)
α= 90.00
β= 116.31(2)
γ= 90.00
V = 1342.5(4)
1542824C6H7NO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=7.1043(5)
b=12.7937(10)
c=14.0302(16)
α= 90.00
β= 90.00
γ= 90.00
V = 1275.2(2)
1542840ACM-CPR
IUCrJ (2014) 1, 2 136-150
a=11.9406(16)
b=21.3081(19)
c=5.1030(14)
α= 92.373(15)
β= 93.003(16)
γ= 85.308(17)
V = 1291.3(4)
1542841ACM-INA
IUCrJ (2014) 1, 2 136-150
a=11.8900(8)
b=4.9621(3)
c=21.4281(14)
α= 90.00
β= 90.663(6)
γ= 90.00
V = 1264.16(14)
1542842C21H18ClNO6,C7H7NO2
IUCrJ (2014) 1, 2 136-150
a=16.959(6)
b=4.7993(15)
c=17.285(5)
α= 90.00
β= 113.55(4)
γ= 90.00
V = 1289.7(8)
1542843C21H18ClNO6,C6H6N2O
IUCrJ (2014) 1, 2 136-150
a=21.7202(15)
b=5.0077(14)
c=11.8457(17)
α= 90.00
β= 93.954(13)
γ= 90.00
V = 1285.4(4)
1542844ACM-PPZ
IUCrJ (2014) 1, 2 136-150
a=7.3994(15)
b=25.6703(19)
c=5.8254(17)
α= 90.162(17)
β= 98.598(16)
γ= 98.315(19)
V = 1082.2(4)
2008394tri-p-tolyltriazine
Acta Crystallographica Section C (1999) 55, 4 698-700
a=15.005(3)
b=20.397(4)
c=6.3420(13)
α= 90.00
β= 90.00
γ= 90.00
V = 1941.0(7)
20105392,2-bis(4,4-diphenyl-2,5-cyclohexadienone)diselenide
Acta Crystallographica Section C (2000) 56, 1 123-124
a=17.4144(16)
b=10.6767(10)
c=15.2187(14)
α= 90.00
β= 90.00
γ= 90.00
V = 2829.6(5)
21020802-Oxa-4-androsten-3,17-dione and 2-Oxa-6beta-hydroxy-4-androsten-3,17-dione
Acta Crystallographica Section B (2000) 56, 3 512-525
a=6.2246(7)
b=12.0140(10)
c=10.9150(10)
α= 90.00
β= 103.090(10)
γ= 90.00
V = 795.04(14)
2102178C17H16O
Acta Crystallographica Section B (2000) 56, 6 1071-1079
a=6.8286(14)
b=8.2407(16)
c=12.658(3)
α= 106.73(3)
β= 98.71(3)
γ= 101.39(3)
V = 652.0(3)
2102180C15H10Cl2O
Acta Crystallographica Section B (2000) 56, 6 1071-1079
a=5.7280(1)
b=11.3620(2)
c=11.5210(1)
α= 117.240(1)
β= 99.250(1)
γ= 96.860(1)
V = 641.866(19)
2102182C27H20O
Acta Crystallographica Section B (2000) 56, 6 1071-1079
a=5.6413(3)
b=10.2599(5)
c=17.3238(9)
α= 100.450(2)
β= 97.790(2)
γ= 95.477(2)
V = 969.51(9)
21021832,4,6-tris-(4-chlorophenoxy)-1,3,5-triazine tribromobenzene
Acta Crystallographica Section B (2000) 56, 6 1080-1084
a=15.250(2)
b=15.250(2)
c=6.8149(14)
α= 90.00
β= 90.00
γ= 120.00
V = 1372.6(4)
2102184C21H12Cl3N3O3,C6H3Br3
Acta Crystallographica Section B (2000) 56, 6 1080-1084
a=15.166(6)
b=15.166(6)
c=6.743(2)
α= 90.
β= 90.
γ= 120.
V = 1343.2(9)
2105533Tetrafluorohydroquinone
Acta Crystallographica Section B (1999) 55, 6 1005-1013
a=6.5533(10)
b=4.8848(10)
c=10.148(2)
α= 90.00
β= 107.990(11)
γ= 90.00
V = 308.97(10)
2105534Tetrabromohydroquinone
Acta Crystallographica Section B (1999) 55, 6 1005-1013
a=8.8907(2)
b=4.73160(10)
c=11.0612(3)
α= 90.00
β= 92.1670(10)
γ= 90.00
V = 464.981(19)
22092824-methylpyridine N-oxide Saccharin
Acta Crystallographica Section E (2006) 62, 6 o2283-o2284
a=14.960(3)
b=12.330(3)
c=7.3565(15)
α= 90.00
β= 100.24(3)
γ= 90.00
V = 1335.3(5)
4116331C9H7ClO2
Journal of the American Chemical Society (1999) 121, 1936-1944
a=7.175(4)
b=25.233(8)
c=8.394(4)
α= 90.0000
β= 90.60(2)
γ= 90.0000
V = 1519.6(12)
4116332C9H7BrO2
Journal of the American Chemical Society (1999) 121, 1936-1944
a=8.306(3)
b=7.261(2)
c=14.269(6)
α= 90.0000
β= 113.13(2)
γ= 90.0000
V = 791.4(5)
4116333C9H7IO2
Journal of the American Chemical Society (1999) 121, 1936-1944
a=8.304(4)
b=7.341(2)
c=14.701(7)
α= 90.0000
β= 113.11(2)
γ= 90.0000
V = 824.3(6)
4116334C11H10O4
Journal of the American Chemical Society (1999) 121, 1936-1944
a=7.260(1)
b=30.507(3)
c=8.252(2)
α= 90
β= 90.724(9)
γ= 90
V = 1827.5(5)
4116335C9H8O2
Journal of the American Chemical Society (1999) 121, 1936-1944
a=8.599(2)
b=11.131(2)
c=14.588(4)
α= 90.0000
β= 94.68(1)
γ= 90.0000
V = 1391.6(6)
4116336C15H12O2
Journal of the American Chemical Society (1999) 121, 1936-1944
a=8.998(2)
b=13.605(2)
c=11.056(2)
α= 90
β= 123.448(9)
γ= 90
V = 1129.3(4)
4116337C10H9NO3
Journal of the American Chemical Society (1999) 121, 1936-1944
a=9.944(1)
b=7.127(1)
c=12.723(2)
α= 90.0000
β= 90.0000
γ= 90.0000
V = 901.7(2)
4116819fluorobenzene
Journal of the American Chemical Society (1998) 120, 8702-8710
a=5.799(2)
b=5.799(2)
c=14.530(7)
α= 90.00
β= 90.00
γ= 90.00
V = 488.6(3)
41168211,4-difluorobenzene
Journal of the American Chemical Society (1998) 120, 8702-8710
a=5.809(2)
b=6.530(2)
c=7.190(2)
α= 90.00
β= 101.89(2)
γ= 90.00
V = 266.89(14)
41168221,3,5-trifluorobenzene
Journal of the American Chemical Society (1998) 120, 8702-8710
a=6.160(2)
b=11.909(3)
c=7.504(2)
α= 90.00
β= 95.47(2)
γ= 90.00
V = 548.0(3)
41168231,2,4,5-tetrafluorobenzene
Journal of the American Chemical Society (1998) 120, 8702-8710
a=4.4719(11)
b=10.285(2)
c=6.342(2)
α= 90.00
β= 107.97(2)
γ= 90.00
V = 277.46(13)
4116825pentafluorobenzene
Journal of the American Chemical Society (1998) 120, 8702-8710
a=12.380(3)
b=9.910(2)
c=9.880(2)
α= 90.00
β= 102.50(3)
γ= 90.00
V = 1183.4(5)
4500670C22H20Br2N4O6S2
Crystal Growth & Design (2011) 11, 5 1930
a=8.181(3)
b=8.421(3)
c=10.250(4)
α= 98.774(6)
β= 95.521(6)
γ= 114.520(6)
V = 624.9(4)
4500671C16H14ClN3O4S
Crystal Growth & Design (2011) 11, 5 1930
a=7.8871(5)
b=7.8871(5)
c=51.100(7)
α= 90.00
β= 90.00
γ= 90.00
V = 3178.7(5)
4500672C24H26N4O8S2
Crystal Growth & Design (2011) 11, 5 1930
a=8.7426(8)
b=5.2061(5)
c=27.7269(19)
α= 90.00
β= 102.935(2)
γ= 90.00
V = 1229.96(18)
4500673C18H17ClN4O7S
Crystal Growth & Design (2011) 11, 5 1930
a=5.2214(4)
b=9.5860(8)
c=20.1540(17)
α= 85.2220(10)
β= 88.7590(10)
γ= 74.8260(10)
V = 970.20(14)
4500674C24H26N4O6S2
Crystal Growth & Design (2011) 11, 5 1930
a=10.3170(9)
b=12.3913(10)
c=20.0553(17)
α= 90.00
β= 103.7280(10)
γ= 90.00
V = 2490.6(4)
4500675C22H19ClN4O7.5S
Crystal Growth & Design (2011) 11, 5 1930
a=8.0230(6)
b=8.3201(6)
c=17.5479(12)
α= 77.7340(10)
β= 77.5200(10)
γ= 81.2860(10)
V = 1110.71(14)
4501115C27H26O8
Crystal Growth & Design (2011) 11, 9 4135
a=7.7321(9)
b=16.1990(19)
c=19.558(3)
α= 90.00
β= 101.095(12)
γ= 90.00
V = 2403.9(6)
4501191C13H12N2O2
Crystal Growth & Design (2011) 11, 10 4594
a=9.0787(11)
b=14.2261(17)
c=17.154(2)
α= 90.00
β= 90.00
γ= 90.00
V = 2215.5(5)
4501192C13H12N2O2
Crystal Growth & Design (2011) 11, 10 4594
a=9.250(4)
b=14.207(4)
c=17.509(10)
α= 90.00
β= 90.00
γ= 90.00
V = 2300.9(18)
4501193C18H18N4O2
Crystal Growth & Design (2011) 11, 10 4594
a=6.8022(8)
b=10.4120(12)
c=23.206(3)
α= 90.00
β= 90.00
γ= 90.00
V = 1643.6(3)
4501194C27H22N4O10
Crystal Growth & Design (2011) 11, 10 4594
a=7.8000(8)
b=13.0415(16)
c=14.0098(15)
α= 64.870(11)
β= 86.132(9)
γ= 85.992(9)
V = 1286.0(3)
45016733,5-Dihydroxybenzoicacid
Crystal Growth & Design (2010) 10, 5 2388
a=14.101(2)
b=22.433(4)
c=14.161(2)
α= 90.00
β= 116.770(2)
γ= 90.00
V = 3999.4(11)
45016753,4-Dihydroxybenzoicacid monohydrate
Crystal Growth & Design (2010) 10, 5 2388
a=12.318(3)
b=3.6448(9)
c=18.182(3)
α= 90.00
β= 112.516(12)
γ= 90.00
V = 754.1(3)
45016763,4-Dihydroxybenzoicacid
Crystal Growth & Design (2010) 10, 5 2388
a=6.8800(8)
b=8.5444(10)
c=17.549(2)
α= 77.982(3)
β= 85.210(2)
γ= 85.581(2)
V = 1003.6(2)
4501677C33H39O22
Crystal Growth & Design (2010) 10, 5 2388
a=9.3556(11)
b=30.024(3)
c=13.4635(15)
α= 90.00
β= 104.955(2)
γ= 90.00
V = 3653.7(7)
45016783,5-Dihydroxybenzoicacid, dioxane
Crystal Growth & Design (2010) 10, 5 2388
a=14.878(6)
b=8.321(4)
c=7.027(3)
α= 90.00
β= 94.826(7)
γ= 90.00
V = 866.9(7)
4501679C32H40O21
Crystal Growth & Design (2010) 10, 5 2388
a=24.977(2)
b=9.1454(9)
c=19.3903(19)
α= 90.00
β= 129.2530(10)
γ= 90.00
V = 3429.8(6)
45016803,5-Dihydroxybenzoicacid
Crystal Growth & Design (2010) 10, 5 2388
a=7.3447(15)
b=15.015(3)
c=6.4840(13)
α= 90.00
β= 111.67(3)
γ= 90.00
V = 664.5(3)
4501763C5H5N3O
Crystal Growth & Design (2010) 10, 9 3931
a=7.1756(14)
b=3.6508(7)
c=10.663(2)
α= 90.00
β= 106.337(3)
γ= 90.00
V = 268.06(9)
4503295Dibromofuchsone
Crystal Growth & Design (2008) 8, 1 140
a=13.9770(6)
b=6.6643(3)
c=17.3378(8)
α= 90.00
β= 97.1440(10)
γ= 90.00
V = 1602.43(12)
45032962,6-Dichlorofuchsone
Crystal Growth & Design (2008) 8, 1 140
a=31.0560(18)
b=17.0663(10)
c=23.9123(14)
α= 90.00
β= 106.5110(10)
γ= 90.00
V = 12151.2(12)
45032972,6-Dichloro-4-(diphenylmethylene)-cyclohexa-2,5-dienone
Crystal Growth & Design (2008) 8, 1 140
a=14.066(5)
b=6.489(2)
c=17.068(6)
α= 90.00
β= 97.853(7)
γ= 90.00
V = 1543.3(9)
45032992,6-Diisopropylfuchsone
Crystal Growth & Design (2008) 8, 1 140
a=10.1830(6)
b=20.7015(13)
c=9.6029(6)
α= 90.00
β= 104.7370(10)
γ= 90.00
V = 1957.7(2)
45033022,6-Diphenylfuchsone
Crystal Growth & Design (2008) 8, 1 140
a=8.0562(6)
b=23.5228(19)
c=11.5384(9)
α= 90.00
β= 90.00
γ= 90.00
V = 2186.6(3)
4503584C34H32N2O8
Crystal Growth & Design (2008) 8, 5 1471
a=14.959(3)
b=9.0758(16)
c=22.131(4)
α= 90.00
β= 90.00
γ= 90.00
V = 3004.6(10)
4503585C34H32N2O8
Crystal Growth & Design (2008) 8, 5 1471
a=5.2770(9)
b=16.174(3)
c=18.145(3)
α= 90.00
β= 95.934(3)
γ= 90.00
V = 1540.4(5)
4503586C42H44Cl6O4
Crystal Growth & Design (2008) 8, 5 1471
a=9.992(2)
b=18.203(4)
c=12.043(2)
α= 90.00
β= 108.20(3)
γ= 90.00
V = 2080.9(8)
4503587C42H48N2O8
Crystal Growth & Design (2008) 8, 5 1471
a=5.2432(7)
b=12.1351(16)
c=14.5958(18)
α= 79.407(2)
β= 79.795(2)
γ= 86.917(2)
V = 898.2(2)
45038002(C16H18FN3O3),2.5H2O
Crystal Growth & Design (2008) 8, 12 4343
a=17.5341(11)
b=8.9942(6)
c=19.9186(13)
α= 90.00
β= 90.4110(10)
γ= 90.00
V = 3141.2(4)
45038018(C16H18FN3O3),8(H2O),O
Crystal Growth & Design (2008) 8, 12 4343
a=17.4911(16)
b=8.9542(8)
c=19.7990(18)
α= 90.00
β= 90.255(2)
γ= 90.00
V = 3100.9(5)
4503802C16H18FN3O3.13,H2O
Crystal Growth & Design (2008) 8, 12 4343
a=8.7445(8)
b=8.9531(8)
c=19.7977(19)
α= 90.00
β= 90.256(2)
γ= 90.00
V = 1550.0(2)
45038321:1.5 Complex of pluoroglucinol and phenazine
Crystal Growth & Design (2008) 8, 12 4546
a=9.8825(12)
b=12.5062(15)
c=16.2270(19)
α= 90.00
β= 100.447(2)
γ= 90.00
V = 1972.3(4)
45038352:3.5 molecular complex of phluoroglucinol and phenazine
Crystal Growth & Design (2008) 8, 12 4546
a=9.4776(10)
b=14.1266(15)
c=17.4609(18)
α= 70.605(2)
β= 82.982(2)
γ= 73.717(2)
V = 2115.6(4)
45038360.5:1 complex of pluoroglucinol and phenazine
Crystal Growth & Design (2008) 8, 12 4546
a=14.159(3)
b=11.943(3)
c=14.249(3)
α= 90.00
β= 102.423(5)
γ= 90.00
V = 2353.1(9)
4504082Venlafaxine hydrochloride
Crystal Growth & Design (2007) 7, 3 476
a=5.887(10)
b=19.37(3)
c=31.41(5)
α= 90.00
β= 92.16(3)
γ= 90.00
V = 3579(10)
4504246C13H10FN3O3
Crystal Growth & Design (2007) 7, 12 2675
a=8.1241(8)
b=12.9932(12)
c=11.6524(11)
α= 90.00
β= 94.967(2)
γ= 90.00
V = 1225.4(2)
4504247C14H10N4O3
Crystal Growth & Design (2007) 7, 12 2675
a=7.919(4)
b=13.692(6)
c=11.777(6)
α= 90.00
β= 94.517(10)
γ= 90.00
V = 1273.0(11)
4504248C13H10IN3O3
Crystal Growth & Design (2007) 7, 12 2675
a=8.4419(17)
b=12.987(3)
c=12.399(3)
α= 90.00
β= 96.59(3)
γ= 90.00
V = 1350.4(5)
4504249N-(3-bromophenyl)-N-(4-nitrophenyl)urea
Crystal Growth & Design (2007) 7, 12 2675
a=8.4078(9)
b=12.7289(13)
c=12.3376(13)
α= 90.00
β= 97.552(2)
γ= 90.00
V = 1308.9(2)
4504250C14H13N3O3
Crystal Growth & Design (2007) 7, 12 2675
a=6.8807(5)
b=12.7415(10)
c=15.2876(11)
α= 84.9720(10)
β= 81.1590(10)
γ= 80.6540(10)
V = 1304.06(17)
4504251C13H11N3O3,C3H7NO
Crystal Growth & Design (2007) 7, 12 2675
a=9.4442(19)
b=7.3883(15)
c=23.863(5)
α= 90.00
β= 97.73(3)
γ= 90.00
V = 1649.9(6)
4504252DMF solvate of N-(4-cyanophenyl)-N-(4-nitrophenyl)urea
Crystal Growth & Design (2007) 7, 12 2675
a=7.9488(7)
b=10.4797(9)
c=11.9563(10)
α= 114.6710(10)
β= 95.441(2)
γ= 101.2000(10)
V = 870.37(13)
4504253N-(4-carboxamidophenyl)-N-(nitrophenyl)urea.DMF
Crystal Growth & Design (2007) 7, 12 2675
a=7.4728(10)
b=10.2624(14)
c=12.5410(17)
α= 105.841(2)
β= 104.695(3)
γ= 95.110(3)
V = 881.9(2)
4504254DMSO solvate of N-(4-iodophenyl)-N-(4-nitrophenyl)-urea
Crystal Growth & Design (2007) 7, 12 2675
a=10.184(2)
b=13.346(3)
c=15.502(3)
α= 66.82(3)
β= 88.22(3)
γ= 68.75(3)
V = 1789.8(9)